FDA opens offices in China

WASHINGTON, Nov. 18 (UPI) -- The U.S. Food and Drug Administration opened three offices in China this week as part of an effort to improve the safety of food imported from the Asian nation.
FDA: Food protection plan shows progress

FDA: Food protection plan shows progress

WASHINGTON, July 2 (UPI) -- The U.S. Food and Drug Administration says its plan to keep U.S. citizens enjoying one of the safest food supplies in the world shows significant progress.

Frank Tori named FDA chief scientist

WASHINGTON, April 9 (UPI) -- The U.S. Food and Drug Administration has appointed Dr. Frank Torti as its principal deputy commissioner and new chief scientist.

FDA names drug research chief

WASHINGTON, March 11 (UPI) -- The U.S. Food and Drug Administration has selected Dr. Janet Woodcock to become the agency's director of drug evaluation and research.

FDA creates pediatric review committee

WASHINGTON, Oct. 25 (UPI) -- The U.S. Food and Drug Administration announced the creation Thursday of an internal pediatric review committee.

Masoudi named FDA associate counsel

WASHINGTON, Oct. 16 (UPI) -- Gerald Masoudi has been named associate general counsel of the food and drug division of the U.S. Department of Health and Human Services.

U.S. FDA, Chinese officials meet in China

WASHINGTON, Oct. 15 (UPI) -- U.S. Food and Drug Administration Commissioner Dr. Andrew von Eschenbach has met with Chinese health officials to discuss the safety of imports.

FDA proposes new sunscreen rules

WASHINGTON, Aug. 23 (UPI) -- The U.S. Food and Drug Administration issued a proposal Thursday setting standards for formulating, testing and labeling over-the-counter sunscreen products.

FDA urged to address nanotechnology safety

WASHINGTON, July 25 (UPI) -- The U.S. Food and Drug Administration's Nanotechnology Task Force released a report Wednesday urging the agency consider addressing nanotechnology risks.

FDA requests diabetes drug warnings

WASHINGTON, June 7 (UPI) -- The U.S. Food and Drug Administration is requesting safety warnings for diabetes drugs Avandia and Actos after they came under congressional scrutiny.

FDA creates new food protection post

WASHINGTON, May 1 (UPI) -- The U.S. Food and Drug Administration has created the position of assistant commissioner for food protection, which will be assumed by Dr. David Acheson.

FDA approves first U.S. bird flu vaccine

WASHINGTON, April 17 (UPI) -- A vaccine designed to protect humans against the H5N1 influenza virus, known as bird flu, has been approved for the first time in the United States.

FDA offers proposal for device fee act

WASHINGTON, April 16 (UPI) -- The U.S. Food and Drug Administration issued a proposal to Congress for reauthorizing the Medical Device User Fee and Modernization Act.

FDA adopts new drug safety measures

WASHINGTON, Jan. 31 (UPI) -- New drug safety measures have been announced by the U.S. Food and Drug Administration in Washington. The FDA said that further steps would be taken to verify that marketed drugs are as safe as their manufacturers claim, including the creation of a program

Senators ask the FDA to halt lab closings

WASHINGTON, Jan. 30 (UPI) -- A bipartisan group of 20 U.S. senators is asking the U.S. Food and Drug Administration to suspend plans to consolidate laboratories.
Page 1 of 2
Andrew von Eschenbach
Acting Food and Drug Administration (FDA) Commissioner Andrew von Eschenbach testifies before a Senate Agriculture Subcommittee hearing on the FDA's FY2007 proposed budget, in Washington on March 14, 2006. (UPI Photo/Kevin Dietsch)

Andrew C. von Eschenbach (born October 30, 1941 in Philadelphia, Pennsylvania) was the Commissioner of the United States Food and Drug Administration from 2006-2009. He became acting Commissioner on September 26, 2005, after the resignation of his predecessor Lester Crawford, and was confirmed as Commissioner by the Senate on December 7, 2006. He was previously the 12th director of the National Cancer Institute.

After graduating from St. Joseph's Preparatory School, Von Eschenbach received his bachelor of science in biology from St. Joseph's University in 1963 and his MD from Georgetown University School of Medicine in 1967. He did residencies at Pennsylvania Hospital in general surgery and urology and taught urology at the University of Pennsylvania School of Medicine. He served in the US Navy Medical Corps with the rank of lieutenant commander from 1968 to 1971.

In 1976, von Eschenbach began his long association with The University of Texas M. D. Anderson Cancer Center, beginning as a urologic oncology fellow and becoming chair of the department of urology in 1983. He was founding director of the Prostate Cancer Research Program in 1996, director of the Genitourinary Cancer Center, and held the Roy M. and Phyllis Gough Huffington Clinical Research Distinguished Chair in Urologic Oncology. Driven by his father's prostate cancer, he specialized in the disease.

This article is licensed under the GNU Free Documentation License.
It uses material from the Wikipedia article "Andrew von Eschenbach."
Most Popular
Hershey's new logo launched, compared to emoji poop
Vanessa Hudgens reunites with 'High School Musical' cast
Oregon girl dies at beach after sand pit collapse
Kate Beckinsale joined by Lucas Till in 'The Disappointments Room'
Ukraine warns of "full-scale war"